Beltran, Eric John N.
HRN: 13-29-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CEFALEXIN 250MG/5ML, 60ML SUSPENSION (BOT)
12/19/2023
12/26/2023
PO
5ml
Every 8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes